Search - tctmd.com

Displaying 541 - 557 of 557

Sort: Relevancy | Date

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

July 18, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Daily News

BARC: New Bleeding Definitions Aim to Standardize Trial Endpoints

June 17, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

June 13, 2011

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

June 10, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Conference News

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

May 18, 2011

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

May 12, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

April 15, 2011

News Daily News

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

March 08, 2011

News Daily News

Meta-analysis: Multivessel PCI Comparable to Culprit-Only Approach in STEMI

March 03, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

January 25, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

January 12, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

January 10, 2011

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.